EGFR and prostate cancer: Our collective research has also shown that CFF-1 exerts potent anti-tumor immunity, effectively hindering tumor growth and metastasis in prostate cancer via the EGFR/JAK1/STAT3 pathway, subsequently inhibiting PD-1/PD-L1 checkpoint signaling.